The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Belkyra 10mg/ml solution for injection

AbbVie LimitedPA1824/021/001

Main Information

Trade NameBelkyra 10mg/ml solution for injection
Active SubstancesDeoxycholic acid
Dosage FormSolution for injection
Licence HolderAbbVie Limited
Licence NumberPA1824/021/001

Group Information

ATC CodeD11AX Other dermatologicals


License statusAuthorised
Licence Issued02/06/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back